Recent findings from Novo Nordisk and Eli Lilly suggest that GLP-1 medications, commonly used for diabetes and weight loss, may also have a beneficial effect on slowing the aging process at a molecular level. This potential anti-aging benefit is being observed alongside their primary therapeutic uses. AI
RANK_REASON Article discusses research findings on a drug's potential side effect, not a core AI development.
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →